| Financial Year |
March 31 2023 |
| Monetary Funds |
560,295,972.96 |
| Held-for-trading Financial Assets |
148,040,561.74 |
| Notes Receivable |
3,485,094.36 |
| Accounts Receivable |
100,789,137.69 |
| Advances to Suppliers |
46,540,318.60 |
| Other Receivables |
62,479,463.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
681,552,030.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,545,542.53 |
| Total Current Assets |
1,705,469,583.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
760,724,528.70 |
| Investment Properties |
16,326,357.39 |
| Fixed Assetes |
302,037,296.92 |
| Under-construction Projects |
5,607,106.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
152,569,327.99 |
| R&D expenses |
13,702,566.64 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
722,222.20 |
| Deferred Income Tax Assets |
23,847,068.52 |
| Other Non-Current Assets |
139,606.00 |
| Sub-Total of Non-Current Assets |
1,796,471,808.94 |
| Total Assets |
3,501,941,392.80 |
| Short-Term Loans |
101,431,475.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
276,440,261.48 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
58,871,495.02 |
| Taxes Payable |
9,161,408.23 |
| Interest Payable |
-- |
| Dividend Payable |
1,040,000.00 |
| Other payables |
97,477,198.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,953,113.92 |
| Other Current Liabilities |
23,256,081.65 |
| Sub-Total of Current Liabilities |
1,094,942,023.84 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
10,115,028.98 |
| Special Payable |
-- |
| Estimatied Liabilities |
5,075,338.38 |
| Deferred Income Tax Liabilities |
352,036.87 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
35,339,333.61 |
| Total Liabilities |
1,130,281,357.45 |
| Paid-In Capital(Or Share Stock) |
1,990,989,926.00 |
| Capital Surplus |
1,046,306,852.92 |
| Surplus Reserve |
439,274,225.51 |
| LESS:Treasury Stock |
125,319,353.22 |
| Undistributed Profits |
-813,425,948.17 |
| Minority Stockholder's Interest |
200,608,126.66 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,171,051,908.69 |
| Owner's Equity（Stockholder's Equity） |
2,371,660,035.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,501,941,392.80 |
